Elosulfase alfa (Vivendy Therapeutics)

N/A

Report date: 2023/01/19 16:46:50

Base Information

Drug NameElosulfase alfa (Vivendy Therapeutics)
Drug Alias Namelysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionN-acetylgalactosamine-6-sulfatase replacementsGlycosaminoglycan degraders
TargetsN-acetylgalactosamine-6-sulfataseGlycosaminoglycan
Therapy Area/IndicationsMucopolysaccharidosis IV
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivendy Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVivendy Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis IV
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A